483 Eli Lilly & Company Jul 2010

483 Eli Lilly & Company Jul 2010

Robert Barbosa FDA, Rebecca Dombrowski FDA, Michele Forster FDA, Jeffrey Meng FDA$119.00 - Available Now

FDA investigators audited the Eli Lilly & Company - Indianapolis, IN, United States facility and issued 2 inspectional observations (via FDA 483) on 28 Jul 2010.

Product details

  • Category: Human Drugs
  • Number of Observations: 2
  • Inspection end: 28 Jul 2010
  • Location: Indianapolis, United States
  • FEI: 1819470
Add To Cart